Medipharm Labs Corp Stock Price History
LABS Stock | CAD 0.07 0.01 7.14% |
Below is the normalized historical share price chart for Medipharm Labs Corp extending back to February 14, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Medipharm Labs stands at 0.07, as last reported on the 13th of December 2024, with the highest price reaching 0.07 and the lowest price hitting 0.06 during the day.
If you're considering investing in Medipharm Stock, it is important to understand the factors that can impact its price. Medipharm Labs appears to be out of control, given 3 months investment horizon. Medipharm Labs Corp has Sharpe Ratio of 0.0502, which conveys that the firm had a 0.0502% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Medipharm Labs, which you can use to evaluate the volatility of the firm. Please exercise Medipharm Labs' Risk Adjusted Performance of 0.0288, downside deviation of 7.68, and Mean Deviation of 4.01 to check out if our risk estimates are consistent with your expectations.
At this time, Medipharm Labs' Total Stockholder Equity is very stable compared to the past year. As of the 13th of December 2024, Common Stock Shares Outstanding is likely to grow to about 381.5 M, while Other Stockholder Equity is likely to drop 0.00. . As of the 13th of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.03, while Price To Sales Ratio is likely to drop 0.68. Medipharm Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.0728 | 50 Day MA 0.0704 | Beta 0.921 |
Medipharm |
Sharpe Ratio = 0.0502
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | LABS | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.7 actual daily | 50 50% of assets are less volatile |
Expected Return
0.29 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Medipharm Labs is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medipharm Labs by adding it to a well-diversified portfolio.
Price Book 0.6388 | Enterprise Value Ebitda (1.82) | Price Sales 0.7622 | Shares Float 382.2 M | Wall Street Target Price 0.1 |
Medipharm Labs Stock Price History Chart
There are several ways to analyze Medipharm Stock price data. The simplest method is using a basic Medipharm candlestick price chart, which shows Medipharm Labs price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 21, 2024 | 0.08 |
Lowest Price | September 24, 2024 | 0.065 |
Medipharm Labs December 13, 2024 Stock Price Synopsis
Various analyses of Medipharm Labs' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Medipharm Stock. It can be used to describe the percentage change in the price of Medipharm Labs from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Medipharm Stock.Medipharm Labs Price Daily Balance Of Power | (1.00) | |
Medipharm Labs Accumulation Distribution | 96,214 | |
Medipharm Labs Price Rate Of Daily Change | 0.93 |
Medipharm Labs December 13, 2024 Stock Price Analysis
Medipharm Stock Price History Data
The price series of Medipharm Labs for the period between Sat, Sep 14, 2024 and Fri, Dec 13, 2024 has a statistical range of 0.02 with a coefficient of variation of 6.38. The daily prices for the period are spread out with arithmetic mean of 0.07. The median price for the last 90 days is 0.07. The company underwent 1:2 stock split on 4th of October 2018.Open | High | Low | Close | Volume | ||
12/12/2024 | 0.07 | 0.07 | 0.06 | 0.07 | 1,250,784 | |
12/11/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 25,680 | |
12/10/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 124,960 | |
12/09/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 45,181 | |
12/06/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 36,337 | |
12/05/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 114,201 | |
12/04/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 239,444 | |
12/03/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 145,100 | |
12/02/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 48,289 | |
11/29/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 50,792 | |
11/28/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 55,100 | |
11/27/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 189,100 | |
11/26/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 105,300 | |
11/25/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 158,443 | |
11/22/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 260,909 | |
11/21/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 144,500 | |
11/20/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 47,100 | |
11/19/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 148,600 | |
11/18/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 48,400 | |
11/15/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 143,313 | |
11/14/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 733,709 | |
11/13/2024 | 0.07 | 0.08 | 0.07 | 0.08 | 374,568 | |
11/12/2024 | 0.07 | 0.08 | 0.07 | 0.07 | 691,372 | |
11/11/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 450,333 | |
11/08/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 227,588 | |
11/07/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 280,600 | |
11/06/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 582,700 | |
11/05/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 322,800 | |
11/04/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 75,000 | |
11/01/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 39,950 | |
10/31/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 54,756 | |
10/30/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 18,535 | |
10/29/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 677,552 | |
10/28/2024 | 0.07 | 0.08 | 0.07 | 0.07 | 204,300 | |
10/25/2024 | 0.08 | 0.08 | 0.07 | 0.07 | 29,328 | |
10/24/2024 | 0.07 | 0.08 | 0.07 | 0.07 | 231,200 | |
10/23/2024 | 0.07 | 0.08 | 0.07 | 0.08 | 14,397 | |
10/22/2024 | 0.08 | 0.08 | 0.07 | 0.07 | 264,579 | |
10/21/2024 | 0.07 | 0.08 | 0.07 | 0.08 | 705,200 | |
10/18/2024 | 0.07 | 0.08 | 0.07 | 0.07 | 389,462 | |
10/17/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 85,523 | |
10/16/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 370,472 | |
10/15/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 29,800 | |
10/11/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 69,657 | |
10/10/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 114,550 | |
10/09/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 93,200 | |
10/08/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 210,960 | |
10/07/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 236,100 | |
10/04/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 285,481 | |
10/03/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 210,200 | |
10/02/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 36,663 | |
10/01/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 46,198 | |
09/30/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 59,890 | |
09/27/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 141,528 | |
09/26/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 206,189 | |
09/25/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 156,759 | |
09/24/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 335,623 | |
09/23/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 91,600 | |
09/20/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 47,217 | |
09/19/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 121,949 | |
09/18/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 84,768 |
About Medipharm Labs Stock history
Medipharm Labs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Medipharm is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Medipharm Labs Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Medipharm Labs stock prices may prove useful in developing a viable investing in Medipharm Labs
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 363.3 M | 381.5 M | |
Net Loss | -27 M | -28.3 M |
Medipharm Labs Quarterly Net Working Capital |
|
Medipharm Labs Stock Technical Analysis
Medipharm Labs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
All Next | Launch Module |
Medipharm Labs Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Medipharm Labs' price direction in advance. Along with the technical and fundamental analysis of Medipharm Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Medipharm to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0288 | |||
Jensen Alpha | 0.1551 | |||
Total Risk Alpha | (0.65) | |||
Sortino Ratio | 0.0058 | |||
Treynor Ratio | (1.74) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Other Information on Investing in Medipharm Stock
Medipharm Labs financial ratios help investors to determine whether Medipharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.